Main menu button

News

Analysis NeuroVive: Cash injection gets new trial going
02 Jul 2019
Analysis NeuroVive: Cash injection gets new trial going
Equity Research
Preview Coor, Continued strength in the second quarter
26 Jun 2019
Preview Coor, Continued strength in the second quarter
Equity Research
Analysis, Brighter: Finansing and ISO news are positives
25 Jun 2019
Analysis, Brighter: Finansing and ISO news are positives
Equity Research
Analysis, Absolicon: Promising framework agreement also gives good guiding
24 Jun 2019
Analysis, Absolicon: Promising framework agreement also gives good guiding
Equity Research
Analysis Ascelia Pharma: Enhancing value
19 Jun 2019
Analysis Ascelia Pharma: Enhancing value
Equity Research
Analysis Saniona: Bridging the gap to 2020
13 Jun 2019
Analysis Saniona: Bridging the gap to 2020
Equity Research
Analysis Follicum: Strenghtens owner base
11 Jun 2019
Analysis Follicum: Strenghtens owner base
Equity Research
Analysis, Bioservo Technologies: Giving a helping hand
11 Jun 2019
Analysis, Bioservo Technologies: Giving a helping hand
Equity Research
Analysis Netmore: More advanced services and greater potential
10 Jun 2019
Analysis Netmore: More advanced services and greater potential
Equity Research
Analysis, Peptonic: New money for growth
10 Jun 2019
Analysis, Peptonic: New money for growth
Equity Research
Analysis, Svenska Aerogel: Financing secured
10 Jun 2019
Analysis, Svenska Aerogel: Financing secured
Equity Research
Analysis Consilium: Still potential in the share
04 Jun 2019
Analysis Consilium: Still potential in the share
Equity Research
Strong revenues and order, but poor profitability
31 May 2019
Strong revenues and order, but poor profitability
Equity Research
Analysis Ascelia Pharma: Clear path to market
28 May 2019
Analysis Ascelia Pharma: Clear path to market
Equity Research
Analysis Amasten: Grown to double its previous size
28 May 2019
Analysis Amasten: Grown to double its previous size
Equity Research
Analysis Nuevolution: Partnership evolves into marriage
27 May 2019
Analysis Nuevolution: Partnership evolves into marriage
Equity Research
Analysis Precise Biometrics: New sectors within a year
27 May 2019
Analysis Precise Biometrics: New sectors within a year
Equity Research
Analysis MaxFastigheter: 30 per cent NAV discount despite expansion
27 May 2019
Analysis MaxFastigheter: 30 per cent NAV discount despite expansion
Equity Research
Analysis Speqta: Good Q1 and strong outlook
24 May 2019
Analysis Speqta: Good Q1 and strong outlook
Equity Research
Analysis Aspire: Strong sequential growth
24 May 2019
Analysis Aspire: Strong sequential growth
Equity Research